4/12/2024 | CV | Market Commentary: Convertibles action thins; Rivian Automotive notes decline; Royal Caribbean pressured
|
4/11/2024 | CV | Market Commentary: Exact Sciences exchanges; NextEra active; Western Digital, Super Micro convertibles gain
|
4/11/2024 | CVLM | Exact Sciences enters exchange agreement for 0.375% convertibles
|
4/2/2024 | CV | Market Commentary: High-grade convertible notes come in amid weak market conditions; Exact Sciences firms
|
3/28/2024 | CV | Market Commentary: Convertibles secondary ends quarter on firm footing; Rexford adds outright; OPKO rises
|
10/4/2023 | CV | Market Commentary: Rivian reopens convertibles primary; Duke Energy, CMS Energy, Southern Co. notes gain
|
10/4/2023 | CV | Market Commentary: Morning Commentary: Duke Energy convertible notes in focus; Exact Sciences active
|
6/21/2023 | CV | Market Commentary: Cerence, World Kinect convertibles on tap; Lumentum lower; Exact Sciences volatile
|
2/23/2023 | CVLM | Exact Sciences enters exchange agreement for two convertibles
|
2/23/2023 | CV | New Issue: Exact Sciences places $500 million 2% convertibles due 2030, up 25%
|
1/9/2023 | CV | Market Commentary: Live Nation convertible notes upsized amid heavy demand; talk tightens; Bilibili active
|
12/20/2022 | CV | Market Commentary: Lucid convertible notes gain; MicroStrategy, Marathon Digital, Exact Sciences active
|
12/20/2022 | CV | Market Commentary: Morning Commentary: Exact Sciences convertible notes remain in focus; shares improve
|
12/19/2022 | CV | Market Commentary: Investment-grade convertibles in focus; Axon drifts lower; Exact Sciences holds gains
|
12/16/2022 | CV | Market Commentary: Novavax volatile outright, mixed on hedge; Guardant Health down; Exact Sciences up
|
4/29/2022 | SP | New Issue: GS Finance sells $9.25 million basket-linked notes tied to 77 stocks
|
1/14/2022 | SP | New Issue: UBS prices $659,400 contingent absolute return autocallables linked to Exact Sciences
|
12/29/2021 | SP | New Issue: UBS prices $200,000 trigger phoenix autocallables linked to Exact Sciences
|
12/15/2021 | SP | New Issue: UBS prices $375,000 trigger phoenix autocallables linked to Exact Sciences
|
12/3/2021 | SP | New Issue: UBS prices $857,000 trigger phoenix autocallables linked to Exact Sciences
|
9/23/2021 | SP | New Issue: UBS prices $370,000 return optimization securities on Exact Sciences
|
8/26/2021 | SP | New Issue: GS Finance prices $13.14 million leveraged basket-linked notes on 179 stocks
|
7/3/2021 | SP | New Issue: Credit Suisse sells $310,000 contingent coupon autocallable yield notes on Exact Sciences
|
6/11/2021 | SP | New Issue: UBS prices $230,000 trigger phoenix autocallables linked to Exact Sciences
|
6/10/2021 | SP | New Issue: UBS prices $2.1 million trigger phoenix autocallables linked to Exact Sciences
|
5/28/2021 | SP | New Issue: UBS prices $99,959 9.49% trigger yield optimization notes linked to Exact Sciences
|
5/19/2021 | SP | New Issue: UBS prices $400,000 trigger phoenix autocallables linked to Exact Sciences
|
5/14/2021 | SP | New Issue: UBS prices $524,215 12.86% trigger yield optimization notes linked to Exact Sciences
|
5/12/2021 | SP | New Issue: UBS prices $100,000 buffered return optimization securities linked to Exact Sciences
|
5/12/2021 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Exact Sciences
|
5/5/2021 | SP | New Issue: UBS prices $120,000 trigger phoenix autocallables linked to Exact Sciences
|
4/29/2021 | SP | New Issue: UBS prices $385,000 trigger phoenix autocallables linked to Exact Sciences
|
4/29/2021 | SP | New Issue: UBS prices $365,000 trigger phoenix autocallables linked to Exact Sciences
|
3/16/2021 | SP | New Issue: Citi sells $799,000 autocallable equity notes on three stocks
|
2/11/2021 | SP | New Issue: UBS prices $120,000 trigger phoenix autocallables linked to Exact Sciences
|
1/11/2021 | CV | Market Commentary: Nio, DocuSign convertible notes on tap; Box tightens talk; Exact Sciences improves
|
12/29/2020 | SP | New Issue: GS Finance sells $1.71 million leveraged basket-linked notes on 23 stocks
|
10/28/2020 | CV | Market Commentary: Morning Commentary: Convertibles secondary quiet as stocks drop; Korea’s Kakao eyed
|
10/27/2020 | CV | Market Commentary: Exact Sciences convertibles in focus; K12 notes improve; Chegg trades down outright
|
10/27/2020 | CV | Market Commentary: Morning Commentary: Exact Sciences convertibles eyed; K12 notes gain post earnings
|
7/29/2020 | SP | New Issue: UBS prices $1 million trigger phoenix autocallables linked to Exact Sciences
|
3/2/2020 | CV | Market Commentary: Square’s $1 billion convertibles, GFL offering eyed; RingCentral, Exact Sciences lower
|
2/28/2020 | CV | Market Commentary: RingCentral prices $1 billion, contracts on debut; Exact Sciences, NuVasive down again
|
2/27/2020 | CV | Exact Sciences greenshoe ups eight-year convertibles to $1.15 billion
|
2/27/2020 | CV | Market Commentary: RingCentral on tap; NuVasive contracts on debut; Bandwidth, Exact Sciences below par
|
2/26/2020 | CV | Market Commentary: NuVasive convertible offering eyed; Bandwidth expands on debt; Exact Sciences volatile
|
2/25/2020 | CV | Market Commentary: GFL units on tap; Bandwidth convertible offering eyed; Exact Sciences notes volatile
|
2/25/2020 | CV | Market Commentary: Morning Commentary: Bandwidth convertible offering eyed; Exact Sciences expands on debut
|
2/25/2020 | CV | New Issue: Exact Sciences sells upsized $1 billion eight-year convertibles at 0.375%, up 27.5%
|
2/24/2020 | CV | Market Commentary: Exact Sciences brings overnight deal; convertibles secondary market weak; Tesla active
|
2/24/2020 | CV | Exact Sciences talks $850 million 0.375% eight-year convertible notes at par, up 27.5%
|
2/11/2020 | SP | New Issue: UBS prices $434,000 trigger phoenix autocallable optimization securities linked to Exact Sciences
|
1/31/2020 | SP | New Issue: UBS prices $365,000 return optimization securities on Exact Sciences
|
1/24/2020 | SP | New Issue: UBS prices $164,000 trigger phoenix autocallables linked to Exact Sciences
|
1/13/2020 | CV | Market Commentary: Luckin Coffee convertible notes in focus; MongoDB gains continue; Exact Sciences down
|
1/7/2020 | SP | New Issue: UBS prices $110,000 trigger phoenix autocallable optimization securities linked to Exact Sciences
|
12/11/2019 | SP | New Issue: UBS prices $1.2 million trigger phoenix autocallable optimization securities linked to Exact Sciences
|
11/26/2019 | SP | New Issue: UBS prices $500,000 trigger phoenix autocallable optimization securities linked to Exact Sciences
|
11/21/2019 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Exact Sciences
|
11/20/2019 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Exact Sciences
|
11/20/2019 | SP | New Issue: UBS prices $142,879 12.26% trigger yield optimization notes linked to Exact Sciences
|
11/15/2019 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Exact Sciences
|
11/15/2019 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Exact Sciences
|
11/15/2019 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Exact Sciences
|
10/31/2019 | CV | Market Commentary: Wayfair convertibles slide outright after earnings disappoint; Western Digital contracts
|
10/31/2019 | CV | Market Commentary: Morning Commentary: Earnings onslaught in focus; Wayfair, Western Digital, Etsy trade
|
10/30/2019 | CV | Market Commentary: Winnebago expands in first-day trading; Granite flat; DTE Energy mandatory trades well
|
10/1/2019 | CV | Market Commentary: Wayfair, Nio, Valaris slide with shares after dour ISM number; some names struggle
|
10/1/2019 | CV | Market Commentary: Morning Commentary: NXP Semiconductors, Pinduoduo convertibles active in early trading
|
9/24/2019 | CV | Market Commentary: Broadcom to price $3 billion of mandatories overnight; Lannett on tap; Pinduoduo eyed
|
9/24/2019 | CV | Market Commentary: Morning Commentary: Planned Pinduoduo convertible notes in focus; Exact Sciences eyed
|
9/18/2019 | SP | New Issue: UBS prices $150,000 trigger phoenix autocallable optimization securities linked to Exact Sciences
|
9/3/2019 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Exact Sciences
|
8/19/2019 | SP | New Issue: UBS prices $175,000 trigger phoenix autocallable optimization securities linked to Exact Sciences
|
8/6/2019 | SP | New Issue: UBS prices $238,000 trigger phoenix autocallable optimization securities linked to Exact Sciences
|
7/30/2019 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Exact Sciences
|
7/29/2019 | CV | Market Commentary: Western Digital convertibles active; Turning Point up; Exact Sciences down outright
|
7/29/2019 | CV | Market Commentary: Morning Commentary: Western Digital convertibles eyed; Exact Sciences down outright
|
7/23/2019 | SP | New Issue: UBS prices $225,000 trigger phoenix autocallable optimization securities linked to Exact Sciences
|
7/16/2019 | SP | New Issue: UBS prices $150,000 trigger phoenix autocallable optimization securities linked to Exact Sciences
|
6/26/2019 | SP | New Issue: UBS prices $255,000 trigger autocallables linked to Exact Sciences
|
6/17/2019 | SP | New Issue: UBS prices $710,000 trigger autocallables linked to Exact Sciences
|
6/12/2019 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Exact Sciences
|
5/24/2019 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Exact Sciences
|
5/15/2019 | CV | Market Commentary: Avantor convertible preferreds on tap; Exact Sciences, Tesla active in secondary trading
|
5/15/2019 | SP | New Issue: UBS prices $99,947 8.03% trigger yield optimization notes linked to Exact Sciences
|
5/15/2019 | CV | Market Commentary: Morning Commentary: Avantor convertible preferreds on tap; Exact Sciences in focus
|
5/3/2019 | SP | New Issue: UBS prices $249,966 8% trigger yield optimization notes linked to Exact Sciences
|
5/3/2019 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallables linked to Exact Sciences
|
4/23/2019 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Exact Sciences
|
4/11/2019 | SP | New Issue: UBS prices $100,000 trigger phoenix autocallable optimization securities linked to Exact Sciences
|
3/27/2019 | CV | Market Commentary: iQIYI’s $1.05 billion convertible notes expand on debut; Exact Sciences trades below par
|
3/8/2019 | CV | Exact Sciences greenshoe ups 0.375% convertibles to $747.5 million
|
3/7/2019 | CV | Market Commentary: Pluralsight convertibles dominate secondary, expand on debut; Exact Sciences keeps expanding
|
3/7/2019 | CV | Market Commentary: Morning Commentary: Pluralsight convertibles dominate secondary, trade up on debut
|
3/6/2019 | CV | Market Commentary: Pluralsight on tap; Ares Capital wrapped around issue price; Exact Sciences expands
|
3/6/2019 | CV | Market Commentary: Morning Commentary: Ares Capital, Exact Sciences price convertible notes at discounts
|
3/6/2019 | CV | New Issue: Exact Sciences sells $650 million 0.375% eight-year convertibles at 99.5, up 27.5%
|
3/5/2019 | CV | Market Commentary: Exact Sciences on tap; Pluralsight looks cheap; Ares Capital reprices; Ctrip.com in focus
|
3/5/2019 | CV | Exact Sciences to price $600 million 0.375% eight-year convertibles at 99.5, up 27.5%
|
1/23/2019 | CV | Market Commentary: ConMed convertibles on tap; Tilray up; Exact Sciences expands; Citrix, Illumina active
|
1/7/2019 | CV | Market Commentary: Convertibles secondary tone improves; Ares Capital dominates trading; biotechs strong
|
10/31/2018 | CV | Market Commentary: Clovis convertibles clobbered; Exact Sciences, FireEye improve; Weatherford rebounds
|
10/18/2018 | CV | Market Commentary: Evolent Health hits the market; Aegean Marine notes eyed; Ligand, Exact Sciences active
|
8/28/2018 | CV | Market Commentary: Biotech names eyed; Wright Medical convertibles up; Exact Sciences reaches new heights
|
8/23/2018 | CV | Market Commentary: MercadoLibre better; Momo brushes par; Illumina levels ‘baffling’; Exact Sciences eyed
|
8/23/2018 | CV | Market Commentary: Morning Commentary: MercadoLibre better outright; Cree flat; Exact Sciences in focus
|
8/22/2018 | CV | Market Commentary: MercadoLibre, Cree hit market with $1.3 billion of convertibles; Exact Sciences expands
|
8/2/2018 | CV | Market Commentary: Greenlight Capital convertibles eyed; Tesla improves; Exact Sciences gets hammered
|
6/12/2018 | CV | Exact Sciences greenshoe lifts 1% convertible add-on to $218.5 million
|
6/8/2018 | CV | Market Commentary: Convertibles primary prices $1.06 billion; Vishay, Mindbody, Exact Sciences active
|
6/8/2018 | CV | Market Commentary: Morning Commentary: Primary prices $1.06 billion; Vishay, Mindbody, Exact Sciences hit the market
|
6/8/2018 | CV | New Issue: Exact Sciences prices upsized $190 million add-on to 1% convertible notes at 106.5
|
6/7/2018 | CV | Exact Sciences announces $150 million add-on to 1% convertible notes
|
5/30/2018 | CV | Market Commentary: Market eyes GDS convertibles; Exact Sciences reaches new heights; Microchip active
|
4/27/2018 | CV | Market Commentary: Western Digital active; AXA offering gets ‘positive reception’; Exact Sciences rebounds
|
4/17/2018 | CV | Market Commentary: South Jersey, Deutsche on tap; Clovis convertibles ‘well received’; oil still catching bids
|
4/12/2018 | CV | Market Commentary: Transocean convertibles in focus; primary quiet; biotech sector firm; Caesars active
|
3/19/2018 | CV | Market Commentary: Apptio convertibles on tap; Guidewire, Zendesk waver below par; Exact Sciences down
|
3/14/2018 | CV | Market Commentary: Zendesk, Supernus on tap; Helix Energy convertibles price cheap, dominate trading
|
2/26/2018 | CV | Market Commentary: Convertibles market opens slowly, picks up in afternoon; Q2, Okta active; biotechs improve
|
2/23/2018 | CV | Market Commentary: Okta’s convertibles expand on debut; Q2 trading activity tempers; Exact Sciences lower
|
2/23/2018 | CV | Market Commentary: Morning Commentary: Okta’s new convertible notes expand on debut; Exact Sciences continues slide
|
2/12/2018 | CV | Market Commentary: Iconix convertibles jump on exchange; Western Digital improves; Endeavour above par
|
2/2/2018 | CV | Market Commentary: Convertibles settle down; ‘rough tape’ for recent biotech deals; Lam Research tumbles
|
2/2/2018 | CV | Market Commentary: Morning Commentary: Convertibles market settles down; ‘rough tape’ for recent biotech deals
|
1/23/2018 | CV | Market Commentary: Teekay eyes deal; Insmed seen as cheap; new paper active; Priceline gains on new CFO
|
1/22/2018 | CV | Market Commentary: Insmed eyes deal; secondary market ‘not moving’; Exact Sciences, optic companies lose footing
|
1/22/2018 | CV | Market Commentary: Morning Commentary: Convertibles ‘not moving’ in early trading; Exact Sciences loses footing
|
1/18/2018 | DD | Market Commentary: Frontier surge continues as amendment launched; energy issues ease; Exact Sciences rebounds
|
1/18/2018 | HY | Market Commentary: Frontier surge continues as amendment launched; energy issues ease; Exact Sciences rebounds
|
1/18/2018 | CV | Market Commentary: Nutanix, Patrick Industries expand on debut; Exact Sciences rebounds; Coupa gains
|
1/17/2018 | DD | Market Commentary: Noble gains on new deal, other energy names struggle; hospitals higher, Frontier firms; Exact Sciences drops
|
1/17/2018 | HY | Market Commentary: Noble gains on new deal, other energy names struggle; hospitals higher, Frontier firms
|
1/17/2018 | CV | Exact Sciences greenshoe ups 1% convertibles due 2025 to $690 million
|
1/17/2018 | CV | Market Commentary: Nutanix, Patrick convertibles eyed; Genocea prices; Exact Sciences is ‘murder today’
|
1/17/2018 | CV | Market Commentary: Morning Commentary: Nutanix, Patrick deals seen cheap, Exact Sciences is ‘murder today’
|
1/16/2018 | CV | Market Commentary: Nutanix, Patrick, Genocea Biosciences to price new deals; Coupa, Exact Sciences quiet; Blackhawk active
|
1/16/2018 | CV | Market Commentary: Morning Commentary: Secondary market off to a slow start; Coupa sees modest expansion
|
1/12/2018 | CV | Market Commentary: Exact Sciences, Coupa dominate trading activity; December’s deals going strong
|
1/12/2018 | CV | Market Commentary: Morning Commentary: Exact Sciences, Coupa bring new paper to market
|
1/12/2018 | CV | New Issue: Exact Sciences prices upsized $600 million seven-year 1% convertibles at 98.75
|
1/11/2018 | CV | New Issue: Exact Sciences prices upsized $600 million seven-year convertibles at 1%, up 37%
|
1/11/2018 | CV | Market Commentary: Exact Sciences to price $500 million; market awaits Coupa; Wheeler adds on; AmTrust active
|
1/11/2018 | CV | Exact Sciences talks $500 million seven-year convertibles at fixed coupon, premium of 1%, up 37%
|
11/13/2017 | SP | New Issue: Credit Suisse prices $1.03 million 16% autocallable reverse convertibles linked to stocks
|
12/6/2011 | PP | Exact Sciences prices $25 million public offering of its common stock
|
12/5/2011 | PP | Exact Sciences plans to conduct a public offering of its common stock
|
8/17/2010 | CVHYPF | Exact Sciences files $150 million shelf for stock, preferreds, debt
|
6/12/2009 | PP | New Issue: Exact Sciences completes $8.2 million private placement of common shares
|
6/11/2009 | PP | New Issue: Exact Sciences announces conclusion of $8.2 million placement of shares
|
1/28/2009 | PP | New Issue: Exact Sciences concludes $6 million private placement of shares
|
1/28/2009 | PP | Market Commentary: SSL boosts acquisition chest; Bank of Queensland, Exact Sciences wrap deals; Seattle Genetics sells stock
|
1/27/2009 | SS | Sequenom begins exchange offer for Exact Sciences; set to end March 24
|
8/18/2008 | SS | Shareholder opposed to sale of Exact Sciences to certain buyers, says new product could boost profits
|
3/18/2008 | SS | Exact Sciences to consider alternatives including possible sale of the company
|
2/28/2008 | SS | Intrinsic Value wants Exact Sciences to sell
|
11/19/2007 | CVHY | Exact Sciences files $50 million shelf
|
10/24/2006 | BT | Exact Sciences: reducing cash burn will take company through 2009
|
10/23/2006 | BT | Exact Sciences ends quarter with $8 million, reports loss of $3.1 million
|
10/17/2006 | BT | Exact Sciences: staff cuts designed to extend cash through 2009
|
9/28/2006 | BT | Market Commentary: Abraxis seeks partner, soars 7%; Somaxon higher; Dynavax slips; Exact Sciences, Immunicon slide
|
6/12/2006 | BT | Exact Sciences sees resolution of FDA's regulatory concerns over Pre-Gen-Plus
|
5/22/2006 | BT | Exact Sciences' stool DNA-testing technology demonstrates 88% sensitivity for colorectal cancer
|
4/13/2006 | BT | Exact Sciences replaces CFO, vice-president of finance, treasurer
|
1/10/2006 | BT | Exact Sciences improves its colon cancer screening technology
|